Carregant...
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers
INTRODUCTION: Ambroxol is used in the treatment of acute and chronic respiratory conditions characterized by abnormal mucus secretion and impaired mucus transport and is available in a variety of formulations. This study aimed to compare the steady-state (SS) pharmacokinetic characteristics of exten...
Guardat en:
| Publicat a: | Pulm Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229136/ https://ncbi.nlm.nih.gov/pubmed/32372294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-020-00116-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|